Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

690.00p
   
  • Change Today:
      10.00p
  • 52 Week High: 1,545.00
  • 52 Week Low: 130.00
  • Currency: UK Pounds
  • Shares Issued: 6.80m
  • Volume: 6,475
  • Market Cap: £46.92m
  • RiskGrade: 340
  • Beta: 0.01

Latest ShareCast News

Hemogenyx shares boosted by partner investment

By Benjamin Chiou

Date: Wednesday 02 Oct 2024

(Sharecast News) - Shares in Hemogenyx Pharmaceuticals jumped on Wednesday after the clinical-stage biopharmaceutical group announced another investment from Prevail Partners via a share subscription at a significant premium to the current market value.

Hermogenyx shares soar on new partnership with Prevail Partners

By Benjamin Chiou

Date: Monday 18 Sep 2023

(Sharecast News) - Shares in biopharma group Hemogenyx surged on Monday after the company received a $0.83m investment from Prevail Partners as it continues to work on its planned clinical trial for leukaemia treatment.

Hemogenyx signs another deal with unnamed global pharma company

By Josh White

Date: Wednesday 23 Oct 2019

(Sharecast News) - Biopharmaceutical group Hemogenyx Pharmaceuticals announced on Wednesday that its wholly-owned subsidiary Immugenyx has entered into a research agreement with a global pharmaceutical company.

Hemogenyx enters collaboration agreement with Or... 19-Oct-2018 ShareCast
Hemogenyx inks lupus collaboration with Johnson ... 15-Oct-2018 ShareCast
Hemogenyx inks development agreement with new ph... 14-May-2018 ShareCast
Hemogenyx flies on back of 'humanised mouse' rep... 26-Feb-2018 ShareCast
Hemogenyx reverses into Silver Falcon, issues sh... 05-Oct-2017 ShareCast
Silver Falcon finally swoops for biotech Hemogen... 11-Sep-2017 ShareCast
 
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 690.00p
Change Today 10.00p
% Change 1.47 %
52 Week High 1,545.00
52 Week Low 130.00
Volume 6,475
Shares Issued 6.80m
Market Cap £46.92m
Beta 0.01
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47% below the market average47% below the market average47% below the market average47% below the market average47% below the market average
56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average
Price Trend
91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average
90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 22-May-2026

Time Volume / Share Price
16:35 6 @ 690.00p
16:35 6 @ 690.00p
16:29 6 @ 690.00p
16:29 100 @ 690.00p
16:05 1 @ 690.00p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page